Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase II Study of Temozolomide and O6-Benzylguanine (O6-BG) in Patients With Temozolomide-Resistant Anaplastic Glioma.

Trial Profile

A Phase II Study of Temozolomide and O6-Benzylguanine (O6-BG) in Patients With Temozolomide-Resistant Anaplastic Glioma.

Status: Discontinued
Phase of Trial: Phase II

Latest Information Update: 11 Feb 2012

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Temozolomide (Primary) ; Benzylguanine
  • Indications Glioma
  • Focus Therapeutic Use
  • Most Recent Events

    • 25 Jan 2012 Planned End Date changed from 1 Dec 2008 to 1 Feb 2009 as reported by ClinicalTrials.gov.
    • 13 Feb 2009 Status changed from active, no longer recruiting to discontinued, as reported by clinicaltrials.gov. AOI Pharmaceuticals decided to terminate the license agreement.
    • 04 Apr 2008 The expected estimated study completion date for this trial has changed from December 2007 to December 2008 according to ClinicalTrials.gov. The estimated final data collection date for the primary outcome measure is June 2008.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top